These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3036733)

  • 1. Mechanisms of vascular actions of PAF.
    Piper PJ; Stanton AW; Stewart AG
    Int J Tissue React; 1987; 9(1):15-7. PubMed ID: 3036733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
    Hu WM; Man RY
    Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
    Hu W; Kinnaird AA; Man RY
    Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart.
    Stahl GL; Lefer AM
    Circ Shock; 1987; 23(3):165-77. PubMed ID: 2827906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary vascular response to platelet-activating factor in the perfused rat heart.
    Man RY; Hu W; Kinnaird AA
    J Lipid Mediat; 1990; 2(2):75-83. PubMed ID: 2135670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the coronary vascular responses to platelet-activating factor in the isolated perfused heart.
    Hu WM; Choy PC; Man RY
    Lipids; 1991 Sep; 26(9):700-4. PubMed ID: 1762514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
    Chen J; Giri SN
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological modification of leukotriene release and coronary constrictor effect in cardiac anaphylaxis.
    Weinerowski P; Wittmann G; Aehringhaus U; Peskar BA
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():47-50. PubMed ID: 3159228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor-induced vasoconstriction in rat isolated, perfused hearts: contribution of cyclo-oxygenase and lipoxygenase arachidonic acid metabolites.
    Stewart AG; Piper PJ
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():163-72. PubMed ID: 3095850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations.
    Coersmeier C; Wittenberg HR; Aehringhaus U; Dreyling KW; Peskar BM; Brune K; Peskar BA
    Agents Actions Suppl; 1986; 19():137-54. PubMed ID: 3092600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative inotropic effect of platelet-activating factor on human myocardium: a pharmacological study.
    Robertson DA; Genovese A; Levi R
    J Pharmacol Exp Ther; 1987 Dec; 243(3):834-9. PubMed ID: 3694533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1986 Jul; 88(3):595-605. PubMed ID: 3091131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary and neutrophil responses to priming effects of platelet-activating factor in pigs.
    Kruse-Elliott KT
    Am J Vet Res; 1997 Dec; 58(12):1386-91. PubMed ID: 9401686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotrienes: possible mediators in bronchial asthma.
    Piper PJ
    Eur J Respir Dis Suppl; 1983; 129():45-64. PubMed ID: 6317422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
    Sybertz EJ; Watkins RW; Baum T; Pula K; Rivelli M
    J Pharmacol Exp Ther; 1985 Jan; 232(1):156-62. PubMed ID: 3917504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig.
    Ezra D; Laurindo FR; Czaja JF; Snyder F; Goldstein RE; Feuerstein G
    Prostaglandins; 1987 Jul; 34(1):41-57. PubMed ID: 3685397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs.
    Fiedler VB; Mardin M; Abram TS
    Basic Res Cardiol; 1987; 82(2):197-208. PubMed ID: 3606544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.